Free Trial
OTCMKTS:AJINY

Ajinomoto 11/6/2023 Earnings Report

Ajinomoto logo
$28.46 -0.35 (-1.21%)
As of 09/19/2025 03:58 PM Eastern

Ajinomoto EPS Results

Actual EPS
$0.26
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ajinomoto Revenue Results

Actual Revenue
$2.41 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ajinomoto Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Ajinomoto's next earnings date is estimated for Wednesday, November 5, 2025, based on past reporting schedules.

Conference Call Resources

Ajinomoto Earnings Headlines

CLSA Sticks to Their Buy Rating for Ajinomoto Co (AJINF)
Buffett, Gates and Bezos Dumping Stocks
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.tc pixel
Ajinomoto Co. Advances Share Repurchase Program
Ajinomoto Co., Inc. Reports Q1 2025 Earnings
See More Ajinomoto Headlines

About Ajinomoto

Ajinomoto (OTCMKTS:AJINY) Co., Inc. is a Tokyo-based global food and chemical corporation best known for pioneering the production of monosodium glutamate (MSG) as a flavor enhancer. Founded in 1909 by chemist Kikunae Ikeda, the company has grown into a diversified enterprise with two core business segments: Foods and Amino Science. Its Foods segment offers a wide array of products, including seasonings, processed frozen foods, ready-to-eat meals, and culinary sauces, catering both to retail consumers and foodservice operators.

In its Amino Science division, Ajinomoto leverages advanced biotechnology to produce amino acids, pharmaceuticals and specialty chemicals. The company develops and manufactures amino acids for use in food fortification, clinical nutrition and animal feed, as well as specialty chemicals for industrial applications. This segment underscores Ajinomoto’s commitment to innovation in health, nutrition and sustainable biochemical solutions.

With a presence in more than 130 countries, Ajinomoto has established a strong global footprint across Asia, the Americas, Europe and Africa. The company operates manufacturing facilities, research laboratories and sales offices worldwide, enabling it to tailor products to regional tastes and dietary needs. Ajinomoto also engages in collaborative research with academic and industry partners to advance food science and amino acid technology.

Under the leadership of President and CEO Mitsuhiro Ito, Ajinomoto continues to pursue a sustainability-focused management strategy. The company has set medium-term goals aimed at reducing environmental impact, enhancing nutritional outcomes and fostering social well-being. Through its longstanding expertise in umami and amino acid science, Ajinomoto strives to address global challenges in nutrition, health and resource efficiency.

View Ajinomoto Profile

More Earnings Resources from MarketBeat